Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9
Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of c...
Saved in:
Published in | Cancer letters Vol. 289; no. 1; pp. 53 - 61 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
01.03.2010
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the
in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture.
Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. |
---|---|
AbstractList | Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using thein vitromodel, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. Abstract Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis.Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to explain the observation that glioblastoma invasion often occurs along existing vasculature, suggesting interactions between the two types of cells. Using the in vitro model, we demonstrate that co-culturing of U87 (human glioblastoma) cells with HMEC-1 (human microvascular endothelial) cells increases the invasiveness of the U87 cells. The enhanced invasiveness correlates with increased expression of MMP-9 in both U87 and HMEC-1 cells, increased expression of cysteine cathepsins B and S and down-regulation of endogenous cell adhesion molecule NCAM in U87 cells. On the other hand, U87 tumour cells significantly enhance the proliferation of co-cultured endothelial cells by a mechanism involving cathepsin B, but not cathepsin S. Furthermore, we demonstrated that increased cell expression and activity of MMP-9 in cell microenvironment is mediated via secretion of SDF-1 by HMEC-1 cells. Selective SDF-1 inhibition impaired the enhanced U87 cell invasion, mostly via down-regulation of MMP-9, but did not alter cathepsin B, although the latter is more relevant for the invasion of U87 cells in mono-culture. Taken together, our study suggests that glioblastoma cells may be attracted by endothelial cells, enhancing their proliferation and underlines the importance of SDF-1, cathepsin B and MMP-9 in the cross-talk between these cells in normoxic conditions. This notion contributes to better understanding and suggests further investigations of the paracrine mechanisms, regulating glioma angiogenesis. |
Author | Kenig, Saša Mueller, Margareta M. Alonso, María Beatriz Durán Lah, Tamara T. |
Author_xml | – sequence: 1 givenname: Saša surname: Kenig fullname: Kenig, Saša email: sasa.kenig@nib.si organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia – sequence: 2 givenname: María Beatriz Durán surname: Alonso fullname: Alonso, María Beatriz Durán organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia – sequence: 3 givenname: Margareta M. surname: Mueller fullname: Mueller, Margareta M. organization: Research Group Tumour and Microenvironment, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany – sequence: 4 givenname: Tamara T. surname: Lah fullname: Lah, Tamara T. email: tamara.lah@nib.si organization: Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, Ljubljana, Slovenia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19700239$$D View this record in MEDLINE/PubMed |
BookMark | eNqVktFuFCEYhYmpsdvqGxhD4oU3OysMwzIYY6LVVpM2mqxeEwb-sawsswLbuE_lK8rsVk1qtPGCcME5H3D-c4QOwhAAoYeUzCih86fLmdHBQ57VhMgZETNCmztoQltRV0K25ABNCCNNxVrGD9FRSktCCG8Ev4cOqRSE1ExO0Pcz74bO65SHlcY6WAzBDvkSvNMeG_A-YROHlKqs_ZcpXoF1OoPF3RYvXp9WdFoMlzoYSDhvVsMmYheudHJD-IO2joN3PUSdx9MCcMFEKNrwGcO3dYS0sw09Nrp41uUg4VdTvJjuUBcXHyp5H93ttU_w4Ho_Rp9O33w8eVudvz97d_LyvDK8lrlqNOtkK5g0opmbuqM1WFGTntkemGGcm1o2PZdzKXhNat1RazvLLWO6GFrLjtGTPbc8-usGUlYrl8Y4dIBhk5RouGSk5fPblYy1lPKGF-XjG8plySuUbyjKyZyUJUbeo2vVpitpq3V0Kx236ufMiuDZXrCbS4ReGZd3meaonVeUqLEgaqn2BVFjQRQRqhSkmJsb5l_8f9te7G1QMr9yEFUyDsrUrYtgsrKD-1-A8S44U0oFW0i_g1CpVkQtxuqOzSWylLZ8uwCe_x1w-_0_APuVAF4 |
CitedBy_id | crossref_primary_10_1007_s11060_010_0158_0 crossref_primary_10_1063_1_5089772 crossref_primary_10_1016_j_neo_2015_10_002 crossref_primary_10_1016_j_freeradbiomed_2013_07_020 crossref_primary_10_1186_s12935_016_0364_8 crossref_primary_10_1158_1541_7786_MCR_11_0411 crossref_primary_10_1016_j_bbcan_2011_12_001 crossref_primary_10_1371_journal_pone_0013973 crossref_primary_10_1002_glia_23309 crossref_primary_10_1007_s12672_024_01547_3 crossref_primary_10_1007_s10014_011_0077_6 crossref_primary_10_1186_s12883_021_02477_1 crossref_primary_10_1016_j_bbamcr_2016_12_021 crossref_primary_10_1016_j_mvr_2010_11_005 crossref_primary_10_18632_oncotarget_2408 crossref_primary_10_1016_j_bbcan_2012_05_004 crossref_primary_10_1016_j_bbalip_2018_07_009 crossref_primary_10_1369_0022155415581689 crossref_primary_10_3390_cancers14030600 crossref_primary_10_1016_j_bbamcr_2020_118781 crossref_primary_10_3109_09553002_2014_930539 crossref_primary_10_1371_journal_pone_0103938 crossref_primary_10_1159_000111048 crossref_primary_10_3892_mmr_2013_1703 crossref_primary_10_1007_s13277_015_4202_8 crossref_primary_10_1038_labinvest_2011_128 crossref_primary_10_1007_s00401_013_1079_8 crossref_primary_10_1016_j_biochi_2013_11_013 crossref_primary_10_1038_s41698_019_0092_3 crossref_primary_10_1088_1054_660X_24_11_115602 crossref_primary_10_4155_fsoa_2016_0094 crossref_primary_10_1002_adhm_201701257 crossref_primary_10_1007_s40139_013_0012_0 crossref_primary_10_12677_acm_2024_14102670 crossref_primary_10_18632_oncotarget_969 crossref_primary_10_1016_j_tips_2011_02_015 crossref_primary_10_1186_s13578_023_01040_4 crossref_primary_10_1093_jnen_nlw054 crossref_primary_10_3390_ijms24087047 crossref_primary_10_2478_raon_2018_0040 crossref_primary_10_1007_s10735_018_9787_y crossref_primary_10_1158_1078_0432_CCR_18_1025 crossref_primary_10_1101_gad_250647_114 crossref_primary_10_1371_journal_pone_0033005 crossref_primary_10_1007_s11060_024_04870_5 crossref_primary_10_1039_D1BM00574J crossref_primary_10_3389_fimmu_2023_1154146 crossref_primary_10_1002_path_4349 crossref_primary_10_3390_brainsci13040542 crossref_primary_10_1002_bit_24775 crossref_primary_10_1016_j_prp_2016_02_020 crossref_primary_10_1515_hsz_2016_0283 crossref_primary_10_1002_advs_202201888 crossref_primary_10_3390_ijms21093162 crossref_primary_10_1016_j_biomaterials_2019_02_024 crossref_primary_10_1016_j_semcancer_2015_08_010 crossref_primary_10_1126_sciadv_adn1607 crossref_primary_10_1038_s41590_022_01215_0 |
Cites_doi | 10.1158/0008-5472.CAN-07-5127 10.1007/BF00144018 10.1016/j.cdp.2005.07.006 10.1242/jcs.00281 10.1016/j.canlet.2005.05.011 10.1016/j.bbrc.2005.07.113 10.1007/s00401-005-0991-y 10.1038/nrc1388 10.4049/jimmunol.154.4.1888 10.1158/0008-5472.CAN-05-4340 10.1182/blood-2005-08-3182 10.1016/S0002-9440(10)63641-3 10.1016/S0021-9258(19)49853-0 10.1016/S1535-6108(04)00111-4 10.2353/ajpath.2008.071197 10.1517/14712598.6.3.257 10.1002/jcb.20720 10.1093/carcin/bgm220 10.3171/jns.1995.83.2.0285 10.1038/nrc1187 10.1038/nrc1477 10.1038/nrc745 10.1515/BC.2001.094 10.1038/nrc1093 10.1093/carcin/bgi183 10.1038/nrc2067 10.1038/nrc1121 10.1096/fj.04-2140fje 10.1007/s007010050301 10.1074/jbc.M107736200 10.1097/01.cej.0000236259.88146.a4 10.1023/B:NEON.0000024241.05346.24 10.1159/000024520 10.1007/s004240000114 10.1016/j.yexcr.2006.12.027 10.1586/14737140.6.7.1087 10.1074/jbc.M509134200 10.1038/35036374 10.1038/sj.onc.1207338 10.1002/path.1876 10.1007/s00701-003-0097-z 10.1515/BC.2004.132 10.1158/1078-0432.CCR-04-1887 10.1038/nrc1075 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1 10.1038/sj.onc.1207616 10.1007/s00701-003-0132-0 |
ContentType | Journal Article |
Copyright | 2009 Elsevier Ireland Ltd Elsevier Ireland Ltd Copyright 2009 Elsevier Ireland Ltd. All rights reserved. Copyright Elsevier Limited Mar 1, 2010 |
Copyright_xml | – notice: 2009 Elsevier Ireland Ltd – notice: Elsevier Ireland Ltd – notice: Copyright 2009 Elsevier Ireland Ltd. All rights reserved. – notice: Copyright Elsevier Limited Mar 1, 2010 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 7TK |
DOI | 10.1016/j.canlet.2009.07.014 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE Neurosciences Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-7980 |
EndPage | 61 |
ExternalDocumentID | 3242189421 19700239 10_1016_j_canlet_2009_07_014 S0304383509005023 1_s2_0_S0304383509005023 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29B 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 6J9 6PF 7-5 71M 8FE 8FH 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AHMBA AI. AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM LK8 M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K UDS VH1 WUQ X7M Z5R ZGI ~G- 3V. 7RV 7X7 8C1 8FI AACTN AFCTW AFKRA AFKWA AJOXV AMFUW AZQEC BBNVY BENPR BHPHI FYUFA GUQSH HCIFZ M1P M2M M2O M7P RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG F3I LCYCR XFK AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7TO 7U9 H94 K9. NAPCQ 7X8 7TK |
ID | FETCH-LOGICAL-c529t-4a3b98739c746c2b12ed720f3dfe3c355c294f596975202ab1ddbd5d33a7468d3 |
IEDL.DBID | .~1 |
ISSN | 0304-3835 1872-7980 |
IngestDate | Fri Jul 11 02:13:15 EDT 2025 Fri Jul 11 07:14:16 EDT 2025 Sat Aug 23 13:22:02 EDT 2025 Thu Apr 03 07:04:55 EDT 2025 Tue Jul 01 01:29:42 EDT 2025 Thu Apr 24 23:04:04 EDT 2025 Fri Feb 23 02:29:35 EST 2024 Sun Feb 23 10:19:53 EST 2025 Tue Aug 26 17:54:52 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HIF VEGF SDF-1 Glioblastoma invasion MIP1α NGF G-CSF bFGF Adhesion molecules: NCAM Angiogenesis Chemokines (CXCL12/SDF-1) GBM Matrix metalloproteases Cysteine cathepsins GM-CSF SF/HGF TGFβ Proteases and proteins: MMP GAPDH Cytokines: MCP-1 GF TIMP stromal-derived factor-1 transforming growth factor β neural cell adhesion molecule basic fibroblast growth factor granulocyte-colony-stimulating factor monocyte chemotactic protein-1 nerve growth factor tissue inhibitor of metalloproteinases growth factors glyceraldehydes 3-phosphate dehydrogenise scatter factor/hepatocyte growth factor glioblastoma vascular endothelial growth factor hypoxia induced factor granulocyte-macrophage colony-stimulating factor matrix metalloproteinase macrophage inflammatory protein 1alpha |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright 2009 Elsevier Ireland Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c529t-4a3b98739c746c2b12ed720f3dfe3c355c294f596975202ab1ddbd5d33a7468d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 19700239 |
PQID | 1506050676 |
PQPubID | 2031080 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_745930856 proquest_miscellaneous_733811545 proquest_journals_1506050676 pubmed_primary_19700239 crossref_citationtrail_10_1016_j_canlet_2009_07_014 crossref_primary_10_1016_j_canlet_2009_07_014 elsevier_sciencedirect_doi_10_1016_j_canlet_2009_07_014 elsevier_clinicalkeyesjournals_1_s2_0_S0304383509005023 elsevier_clinicalkey_doi_10_1016_j_canlet_2009_07_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-03-01 |
PublicationDateYYYYMMDD | 2010-03-01 |
PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland – name: Clare |
PublicationTitle | Cancer letters |
PublicationTitleAlternate | Cancer Lett |
PublicationYear | 2010 |
Publisher | Elsevier Ireland Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier Limited |
References | Bergers, Benjamin (bib5) 2003; 3 Scala, Ottaiano, Ascierto, Cavalli, Simeone, Giuliano, Napolitano, Franco, Botti, Castello (bib40) 2005; 11 Lah, Duran Alonso, Van Noorden (bib7) 2006; 6 Rosenman, Shrikant, Dubb, Benveniste, Ransohoff (bib22) 1995; 154 Egeblad, Werb (bib30) 2002; 2 Bergers, Brekken, McMahon, Vu, Itoh, Tamaki, Tanzawa, Thorpe, Itohara, Werb, Hanahan (bib52) 2000; 2 Kos, Lah (bib28) 1998; 5 Wang, Sun, Kitamoto, Yang, Grubb, Chapman, Kalluri, Shi (bib41) 2006; 281 Semenza (bib4) 2003; 3 Salmaggi, Gelati, Pollo, Frigerio, Eoli, Silvani, Broggi, Ciusani, Croci, Boiardi, De Rossi (bib50) 2004; 67 Joyce, Baruch, Chehade, Meyer-Morse, Giraudo, Tsai, Greenbaum, Hager, Bogyo, Hanahan (bib36) 2004; 5 Tews, Nissen (bib21) 1998; 18 Yang, Chen, Jiang, Wang, Chen, Zhao, Feng, Xin, Shi, Bian (bib46) 2005; 335 Hong, Jiang, Kalkanis, Zhang, Zhang, DeCarvalho, Katakowski, Bobbitt, Mikkelsen, Chopp (bib44) 2006; 236 Jedeszko, Sloane (bib29) 2004; 385 Friedl, Wolf (bib8) 2003; 3/5 Tu, Ortega-Cava, Chen, Fernandes, Cavallo-Medved, Sloane, Band, Band (bib9) 2008; 86/22 Sathornsumetee, Rich (bib2) 2006; 6 Flannery, Gibson, Mirakhur, McQuaid, Greenan, Trimble, Walker, McCormick, Johnston (bib35) 2003; 163 Mikkelsen, Yan, Ho, Sameni, Sloane, Rosenblum (bib15) 1995; 83 Parmo-Cabanas, Molina-Ortiz, Matias-Roman, Garcia-Bernal, Carvajal-Vergara, Valle, Pandiella, Arroyo, Teixido (bib53) 2006; 208 Zeelenberg, Ruuls-Van Stalle, Roos (bib42) 2003; 63 Albini, Sporn (bib27) 2007; 7 Strojnik, Kavalar, Trinkaus, Lah (bib33) 2005; 29 Levičar, Nuttall, Lah (bib11) 2003; 145 Charalambous, Virrey, Kardosh, Jabbour, Qazi-Abdullah, Pen, Zidovetzki, Schonthal, Chen, Hofman (bib38) 2007; 313 Kondraganti, Mohanam, Chintala, Kin, Jasti, Nirmala, Lakka, Adachi, Kyritsis, Ali-Osman, Sawaya, Fuller, Rao (bib19) 2000; 60 Zagzag, Esancay, Mendez, Yee, Smirnova, Huang, Chiribon, Lukyanov, Liu, Newcomb (bib51) 2008; 173 Scotton, Wilson, Scott, Stamp, Wilbanks, Fricker, Bridger, Balkwill (bib43) 2002; 62 Rao (bib10) 2003; 3 von Bulow, Hayen, Hartmann, Mueller-Klieser, Allolio, Nehls (bib6) 2001; 193 Sameni, Dosescu, Sloane (bib16) 2001; 382 Lakka, Gondi, Yanamandra, Olivero, Dinh, Gujrati, Rao (bib17) 2004; 23 Balkwill (bib25) 2004; 4 Khodarev, Yu, Labay, Darga, Brown, Mauceri, Yassari, Gupta, Weichselbaum (bib37) 2003; 116 Goldbrunner, Bernstein, Tonn (bib20) 1999; 141 Masson, de la Ballina, Munaut, Wielockx, Jost, Maillard, Blacher, Bajou, Itoh, Itohara, Werb, Libert, Foidart, Noel (bib31) 2005; 19 Park, Park, Kwak, Lee, Kim, Lee, Park, Rhee, Hong (bib32) 2006; 66 Premzl, Turk, Kos (bib18) 2006; 97 Burger, Kipps (bib26) 2006; 107 Folkman, Shing (bib3) 1992; 267 Sivaparvathi, Sawaya, Wang, Rayford, Yamamoto, Liotta, Nicolson, Rao (bib14) 1995; 13 Mueller, Fusenig (bib24) 2004; 4 Tang, Tan, Fu, Yang (bib48) 2008; 29 Yuecheng, Xiaoyan (bib47) 2007; 16 Strojnik, Zajc, Bervar, Zidanik, Golouh, Kos, Dolenc, Lah (bib12) 2000; 439 Mueller, Werbowetski, Del Maestro (bib23) 2003; 145 Zajc, Hreljac, Lah (bib34) 2006; 26 Zhang, Sarkar, Yong (bib45) 2005; 26 Strojnik, Kos, Zidanik, Lah (bib13) 1999; 5 McQuibban, Butler, Gong, Bendall, Power, Clark-Lewis, Overall (bib49) 2001; 276 Yanamandra, Gumidyala, Waldron, Gujrati, Olivero, Dinh, Rao, Mohanam (bib39) 2004; 23 Ohgaki, Kleihues (bib1) 2005; 109 Joyce (10.1016/j.canlet.2009.07.014_bib36) 2004; 5 Mueller (10.1016/j.canlet.2009.07.014_bib24) 2004; 4 Masson (10.1016/j.canlet.2009.07.014_bib31) 2005; 19 Tu (10.1016/j.canlet.2009.07.014_bib9) 2008; 86/22 Zajc (10.1016/j.canlet.2009.07.014_bib34) 2006; 26 Yuecheng (10.1016/j.canlet.2009.07.014_bib47) 2007; 16 Park (10.1016/j.canlet.2009.07.014_bib32) 2006; 66 Strojnik (10.1016/j.canlet.2009.07.014_bib13) 1999; 5 Sathornsumetee (10.1016/j.canlet.2009.07.014_bib2) 2006; 6 Flannery (10.1016/j.canlet.2009.07.014_bib35) 2003; 163 Ohgaki (10.1016/j.canlet.2009.07.014_bib1) 2005; 109 Strojnik (10.1016/j.canlet.2009.07.014_bib12) 2000; 439 Kondraganti (10.1016/j.canlet.2009.07.014_bib19) 2000; 60 Mikkelsen (10.1016/j.canlet.2009.07.014_bib15) 1995; 83 Zhang (10.1016/j.canlet.2009.07.014_bib45) 2005; 26 Scala (10.1016/j.canlet.2009.07.014_bib40) 2005; 11 Sameni (10.1016/j.canlet.2009.07.014_bib16) 2001; 382 Premzl (10.1016/j.canlet.2009.07.014_bib18) 2006; 97 Semenza (10.1016/j.canlet.2009.07.014_bib4) 2003; 3 Goldbrunner (10.1016/j.canlet.2009.07.014_bib20) 1999; 141 Parmo-Cabanas (10.1016/j.canlet.2009.07.014_bib53) 2006; 208 Levičar (10.1016/j.canlet.2009.07.014_bib11) 2003; 145 Charalambous (10.1016/j.canlet.2009.07.014_bib38) 2007; 313 Albini (10.1016/j.canlet.2009.07.014_bib27) 2007; 7 Tews (10.1016/j.canlet.2009.07.014_bib21) 1998; 18 Khodarev (10.1016/j.canlet.2009.07.014_bib37) 2003; 116 McQuibban (10.1016/j.canlet.2009.07.014_bib49) 2001; 276 Jedeszko (10.1016/j.canlet.2009.07.014_bib29) 2004; 385 Strojnik (10.1016/j.canlet.2009.07.014_bib33) 2005; 29 Yang (10.1016/j.canlet.2009.07.014_bib46) 2005; 335 Folkman (10.1016/j.canlet.2009.07.014_bib3) 1992; 267 Sivaparvathi (10.1016/j.canlet.2009.07.014_bib14) 1995; 13 Lakka (10.1016/j.canlet.2009.07.014_bib17) 2004; 23 Rosenman (10.1016/j.canlet.2009.07.014_bib22) 1995; 154 Egeblad (10.1016/j.canlet.2009.07.014_bib30) 2002; 2 Zeelenberg (10.1016/j.canlet.2009.07.014_bib42) 2003; 63 Zagzag (10.1016/j.canlet.2009.07.014_bib51) 2008; 173 Burger (10.1016/j.canlet.2009.07.014_bib26) 2006; 107 Tang (10.1016/j.canlet.2009.07.014_bib48) 2008; 29 Yanamandra (10.1016/j.canlet.2009.07.014_bib39) 2004; 23 Lah (10.1016/j.canlet.2009.07.014_bib7) 2006; 6 von Bulow (10.1016/j.canlet.2009.07.014_bib6) 2001; 193 Bergers (10.1016/j.canlet.2009.07.014_bib5) 2003; 3 Balkwill (10.1016/j.canlet.2009.07.014_bib25) 2004; 4 Hong (10.1016/j.canlet.2009.07.014_bib44) 2006; 236 Friedl (10.1016/j.canlet.2009.07.014_bib8) 2003; 3/5 Bergers (10.1016/j.canlet.2009.07.014_bib52) 2000; 2 Scotton (10.1016/j.canlet.2009.07.014_bib43) 2002; 62 Salmaggi (10.1016/j.canlet.2009.07.014_bib50) 2004; 67 Rao (10.1016/j.canlet.2009.07.014_bib10) 2003; 3 Kos (10.1016/j.canlet.2009.07.014_bib28) 1998; 5 Wang (10.1016/j.canlet.2009.07.014_bib41) 2006; 281 Mueller (10.1016/j.canlet.2009.07.014_bib23) 2003; 145 |
References_xml | – volume: 86/22 start-page: 9147 year: 2008 end-page: 9156 ident: bib9 article-title: Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion vi secreted lysosomes in the v-Src fibroblasts publication-title: Cancer Res. – volume: 335 start-page: 523 year: 2005 end-page: 528 ident: bib46 article-title: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor publication-title: Biochem. Biophys. Rest. Commun. – volume: 5 start-page: 1349 year: 1998 end-page: 1361 ident: bib28 article-title: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review) publication-title: Oncol. Rep. – volume: 62 start-page: 5930 year: 2002 end-page: 5938 ident: bib43 article-title: Multiple actions of the chemokine CXCL12 on epithelial tumour cells in human ovarian cancer publication-title: Cancer Rest. – volume: 173 start-page: 545 year: 2008 end-page: 560 ident: bib51 article-title: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures publication-title: Am. J. Pathol. – volume: 267 start-page: 10931 year: 1992 end-page: 10934 ident: bib3 article-title: Angiogenesis publication-title: J. Biol. Chem. – volume: 208 start-page: 108 year: 2006 end-page: 118 ident: bib53 article-title: Role of metaloproteinases MMP9 and MT1-MMP in CXCL2-promoted myleoma cell invasion across basement membranes publication-title: J. Pathol. – volume: 3 start-page: 401 year: 2003 end-page: 410 ident: bib5 article-title: Tumourigenesis and the angiogenic switch publication-title: Nat. Rev. Cancer – volume: 19 start-page: 234 year: 2005 end-page: 236 ident: bib31 article-title: Contribution of host MMP-2 and MMP-9 to promote tumour vascularization and invasion of malignant keratinocytes publication-title: FASEB J. – volume: 5 start-page: 443 year: 2004 end-page: 453 ident: bib36 article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumourigenesis publication-title: Cancer Cell – volume: 7 start-page: 139 year: 2007 end-page: 147 ident: bib27 article-title: The tumour microenvirnment as a target for chemoprevetion publication-title: Nat. Rev. Cancer – volume: 66 start-page: 8511 year: 2006 end-page: 8519 ident: bib32 article-title: Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways publication-title: Cancer Rest. – volume: 193 start-page: 367 year: 2001 end-page: 376 ident: bib6 article-title: Endothelial capillaries chemotactically attract tumour cells publication-title: J. Pathol. – volume: 3 start-page: 489 year: 2003 end-page: 501 ident: bib10 article-title: Molecular mechanisms of glioma invasiveness: the role of proteases publication-title: Nat. Rev. Cancer – volume: 18 start-page: 271 year: 1998 end-page: 284 ident: bib21 article-title: Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumours publication-title: Invas. Metast. – volume: 3 start-page: 721 year: 2003 end-page: 732 ident: bib4 article-title: Targeting HIF-1 for cancer therapy publication-title: Nat. Rev. Cancer – volume: 145 start-page: 825 year: 2003 end-page: 838 ident: bib11 article-title: Proteases in brain tumour progression publication-title: Acta Neurochir. (Wien.) – volume: 116 start-page: 1013 year: 2003 end-page: 1022 ident: bib37 article-title: Tumour–endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells publication-title: J. Cell Sci. – volume: 276 start-page: 43503 year: 2001 end-page: 43508 ident: bib49 article-title: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 publication-title: J. Biol. Chem. – volume: 29 start-page: 448 year: 2005 end-page: 455 ident: bib33 article-title: Cathepsin L in glioma progression: comparison with cathepsin B publication-title: Cancer Detect. Prev. – volume: 4 start-page: 839 year: 2004 end-page: 849 ident: bib24 article-title: Friends or foes – bipolar effects of the tumour stroma in cancer publication-title: Nat. Rev. Cancer – volume: 163 start-page: 175 year: 2003 end-page: 182 ident: bib35 article-title: The clinical significance of cathepsin S expression in human astrocytomas publication-title: Am. J. Pathol. – volume: 63 start-page: 3833 year: 2003 end-page: 3839 ident: bib42 article-title: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases publication-title: Cancer Rest. – volume: 281 start-page: 6020 year: 2006 end-page: 6029 ident: bib41 article-title: Cathepsin S controls angiogenesis and tumour growth via matrix-derived angiogenic factors publication-title: J. Biol. Chem. – volume: 107 start-page: 1761 year: 2006 end-page: 1767 ident: bib26 article-title: CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment publication-title: Blood – volume: 2 start-page: 737 year: 2000 end-page: 744 ident: bib52 article-title: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis publication-title: Nat. Cell Biol. – volume: 16 start-page: 430 year: 2007 end-page: 435 ident: bib47 article-title: Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2 publication-title: Eur. J. Cancer Prev. – volume: 145 start-page: 999 year: 2003 end-page: 1008 ident: bib23 article-title: Soluble factors involved in glioma invasion publication-title: Acta Neurochir. (Wien.) – volume: 23 start-page: 2224 year: 2004 end-page: 2230 ident: bib39 article-title: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis publication-title: Oncogene – volume: 26 start-page: 2069 year: 2005 end-page: 2077 ident: bib45 article-title: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase publication-title: Carcinogenesis – volume: 11 start-page: 1835 year: 2005 end-page: 1841 ident: bib40 article-title: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma publication-title: Clin. Cancer Rest. – volume: 2 start-page: 161 year: 2002 end-page: 174 ident: bib30 article-title: New functions for the matrix metalloproteinases in cancer progression publication-title: Nat. Rev. Cancer – volume: 313 start-page: 1192 year: 2007 end-page: 1202 ident: bib38 article-title: Glioma-associated endothelial cells show evidence of replicative senescence publication-title: Exp. Cell Rest. – volume: 29 start-page: 35 year: 2008 end-page: 43 ident: bib48 article-title: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis publication-title: Carcinogenesis – volume: 3/5 start-page: 362 year: 2003 end-page: 374 ident: bib8 article-title: Tumour-cell invasion and migration: diversity and escape mechanisms publication-title: Nat. Rev. Cancer – volume: 4 start-page: 540 year: 2004 end-page: 550 ident: bib25 article-title: Cancer and the chemokine network publication-title: Nat. Rev. Cancer – volume: 382 start-page: 785 year: 2001 end-page: 788 ident: bib16 article-title: Imaging proteolysis by living human glioma cells publication-title: Biol. Chem. – volume: 385 start-page: 1017 year: 2004 end-page: 1027 ident: bib29 article-title: Cysteine cathepsins in human cancer publication-title: Biol. Chem. – volume: 60 start-page: 6851 year: 2000 end-page: 6855 ident: bib19 article-title: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion publication-title: Cancer Rest. – volume: 109 start-page: 93 year: 2005 end-page: 108 ident: bib1 article-title: Epidemiology and etiology of gliomas publication-title: Acta Neuropathpl. – volume: 23 start-page: 4681 year: 2004 end-page: 4689 ident: bib17 article-title: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis publication-title: Oncogene – volume: 141 start-page: 295 year: 1999 end-page: 305 ident: bib20 article-title: Cell–extracellular matrix interaction in glioma invasion publication-title: Acta Neurochir. (Wien.) – volume: 439 start-page: R122 year: 2000 end-page: R123 ident: bib12 article-title: Cathepsin B and its inhibitor stefin A in brain tumours publication-title: Pflugers Arch. – volume: 67 start-page: 305 year: 2004 end-page: 317 ident: bib50 article-title: CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells publication-title: J. Neuro-Oncol. – volume: 97 start-page: 1230 year: 2006 end-page: 1240 ident: bib18 article-title: Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro publication-title: J. Cell Biochem. – volume: 6 start-page: 257 year: 2006 end-page: 279 ident: bib7 article-title: Antiprotease therapy in cancer: hot or not? publication-title: Expert Opin. Biol. Ther. – volume: 6 start-page: 1087 year: 2006 end-page: 1104 ident: bib2 article-title: New treatment strategies for malignant gliomas publication-title: Expert Rev. Anticancer Ther. – volume: 83 start-page: 285 year: 1995 end-page: 289 ident: bib15 article-title: Immunolocalization of cathepsin B in human glioma: implications for tumour invasion and angiogenesis publication-title: J. Neurosurg. – volume: 236 start-page: 39 year: 2006 end-page: 45 ident: bib44 article-title: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion publication-title: Cancer Lett. – volume: 13 start-page: 49 year: 1995 end-page: 56 ident: bib14 article-title: Overexpression and localization of cathepsin B during the progression of human gliomas publication-title: Clin. Exp. Metast. – volume: 154 start-page: 1888 year: 1995 end-page: 1899 ident: bib22 article-title: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines publication-title: J. Immunol. – volume: 26 start-page: 3357 year: 2006 end-page: 3364 ident: bib34 article-title: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics publication-title: Anticancer Rest. – volume: 5 start-page: 559 year: 1999 end-page: 567 ident: bib13 article-title: Cathepsin B immunohistochemical staining in tumour, endothelial cells is a new prognostic factor for survival in patients with brain tumours publication-title: Clin. Cancer Rest. – volume: 86/22 start-page: 9147 year: 2008 ident: 10.1016/j.canlet.2009.07.014_bib9 article-title: Lysosomal cathepsins B participates in the podosome-mediated extracellular matrix degradation and invasion vi secreted lysosomes in the v-Src fibroblasts publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-07-5127 – volume: 63 start-page: 3833 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib42 article-title: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases publication-title: Cancer Rest. – volume: 62 start-page: 5930 year: 2002 ident: 10.1016/j.canlet.2009.07.014_bib43 article-title: Multiple actions of the chemokine CXCL12 on epithelial tumour cells in human ovarian cancer publication-title: Cancer Rest. – volume: 13 start-page: 49 year: 1995 ident: 10.1016/j.canlet.2009.07.014_bib14 article-title: Overexpression and localization of cathepsin B during the progression of human gliomas publication-title: Clin. Exp. Metast. doi: 10.1007/BF00144018 – volume: 29 start-page: 448 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib33 article-title: Cathepsin L in glioma progression: comparison with cathepsin B publication-title: Cancer Detect. Prev. doi: 10.1016/j.cdp.2005.07.006 – volume: 116 start-page: 1013 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib37 article-title: Tumour–endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells publication-title: J. Cell Sci. doi: 10.1242/jcs.00281 – volume: 236 start-page: 39 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib44 article-title: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion publication-title: Cancer Lett. doi: 10.1016/j.canlet.2005.05.011 – volume: 335 start-page: 523 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib46 article-title: Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor publication-title: Biochem. Biophys. Rest. Commun. doi: 10.1016/j.bbrc.2005.07.113 – volume: 109 start-page: 93 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib1 article-title: Epidemiology and etiology of gliomas publication-title: Acta Neuropathpl. doi: 10.1007/s00401-005-0991-y – volume: 4 start-page: 540 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib25 article-title: Cancer and the chemokine network publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1388 – volume: 154 start-page: 1888 year: 1995 ident: 10.1016/j.canlet.2009.07.014_bib22 article-title: Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines publication-title: J. Immunol. doi: 10.4049/jimmunol.154.4.1888 – volume: 66 start-page: 8511 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib32 article-title: Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways publication-title: Cancer Rest. doi: 10.1158/0008-5472.CAN-05-4340 – volume: 107 start-page: 1761 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib26 article-title: CXCR4: a key receptor in the crosstalk between tumour cells and their microenvironment publication-title: Blood doi: 10.1182/blood-2005-08-3182 – volume: 163 start-page: 175 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib35 article-title: The clinical significance of cathepsin S expression in human astrocytomas publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63641-3 – volume: 267 start-page: 10931 year: 1992 ident: 10.1016/j.canlet.2009.07.014_bib3 article-title: Angiogenesis publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)49853-0 – volume: 5 start-page: 443 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib36 article-title: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumourigenesis publication-title: Cancer Cell doi: 10.1016/S1535-6108(04)00111-4 – volume: 173 start-page: 545 year: 2008 ident: 10.1016/j.canlet.2009.07.014_bib51 article-title: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2008.071197 – volume: 6 start-page: 257 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib7 article-title: Antiprotease therapy in cancer: hot or not? publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.6.3.257 – volume: 97 start-page: 1230 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib18 article-title: Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro publication-title: J. Cell Biochem. doi: 10.1002/jcb.20720 – volume: 29 start-page: 35 year: 2008 ident: 10.1016/j.canlet.2009.07.014_bib48 article-title: Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis publication-title: Carcinogenesis doi: 10.1093/carcin/bgm220 – volume: 83 start-page: 285 year: 1995 ident: 10.1016/j.canlet.2009.07.014_bib15 article-title: Immunolocalization of cathepsin B in human glioma: implications for tumour invasion and angiogenesis publication-title: J. Neurosurg. doi: 10.3171/jns.1995.83.2.0285 – volume: 3 start-page: 721 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib4 article-title: Targeting HIF-1 for cancer therapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1187 – volume: 4 start-page: 839 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib24 article-title: Friends or foes – bipolar effects of the tumour stroma in cancer publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1477 – volume: 5 start-page: 1349 year: 1998 ident: 10.1016/j.canlet.2009.07.014_bib28 article-title: Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review) publication-title: Oncol. Rep. – volume: 2 start-page: 161 year: 2002 ident: 10.1016/j.canlet.2009.07.014_bib30 article-title: New functions for the matrix metalloproteinases in cancer progression publication-title: Nat. Rev. Cancer doi: 10.1038/nrc745 – volume: 382 start-page: 785 year: 2001 ident: 10.1016/j.canlet.2009.07.014_bib16 article-title: Imaging proteolysis by living human glioma cells publication-title: Biol. Chem. doi: 10.1515/BC.2001.094 – volume: 3 start-page: 401 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib5 article-title: Tumourigenesis and the angiogenic switch publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1093 – volume: 26 start-page: 2069 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib45 article-title: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase publication-title: Carcinogenesis doi: 10.1093/carcin/bgi183 – volume: 60 start-page: 6851 year: 2000 ident: 10.1016/j.canlet.2009.07.014_bib19 article-title: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion publication-title: Cancer Rest. – volume: 26 start-page: 3357 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib34 article-title: Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics publication-title: Anticancer Rest. – volume: 7 start-page: 139 year: 2007 ident: 10.1016/j.canlet.2009.07.014_bib27 article-title: The tumour microenvirnment as a target for chemoprevetion publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2067 – volume: 5 start-page: 559 year: 1999 ident: 10.1016/j.canlet.2009.07.014_bib13 article-title: Cathepsin B immunohistochemical staining in tumour, endothelial cells is a new prognostic factor for survival in patients with brain tumours publication-title: Clin. Cancer Rest. – volume: 3 start-page: 489 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib10 article-title: Molecular mechanisms of glioma invasiveness: the role of proteases publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1121 – volume: 19 start-page: 234 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib31 article-title: Contribution of host MMP-2 and MMP-9 to promote tumour vascularization and invasion of malignant keratinocytes publication-title: FASEB J. doi: 10.1096/fj.04-2140fje – volume: 141 start-page: 295 year: 1999 ident: 10.1016/j.canlet.2009.07.014_bib20 article-title: Cell–extracellular matrix interaction in glioma invasion publication-title: Acta Neurochir. (Wien.) doi: 10.1007/s007010050301 – volume: 276 start-page: 43503 year: 2001 ident: 10.1016/j.canlet.2009.07.014_bib49 article-title: Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M107736200 – volume: 16 start-page: 430 year: 2007 ident: 10.1016/j.canlet.2009.07.014_bib47 article-title: Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2 publication-title: Eur. J. Cancer Prev. doi: 10.1097/01.cej.0000236259.88146.a4 – volume: 67 start-page: 305 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib50 article-title: CXCL12 in malignant glial tumours: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells publication-title: J. Neuro-Oncol. doi: 10.1023/B:NEON.0000024241.05346.24 – volume: 18 start-page: 271 year: 1998 ident: 10.1016/j.canlet.2009.07.014_bib21 article-title: Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumours publication-title: Invas. Metast. doi: 10.1159/000024520 – volume: 439 start-page: R122 year: 2000 ident: 10.1016/j.canlet.2009.07.014_bib12 article-title: Cathepsin B and its inhibitor stefin A in brain tumours publication-title: Pflugers Arch. doi: 10.1007/s004240000114 – volume: 313 start-page: 1192 year: 2007 ident: 10.1016/j.canlet.2009.07.014_bib38 article-title: Glioma-associated endothelial cells show evidence of replicative senescence publication-title: Exp. Cell Rest. doi: 10.1016/j.yexcr.2006.12.027 – volume: 6 start-page: 1087 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib2 article-title: New treatment strategies for malignant gliomas publication-title: Expert Rev. Anticancer Ther. doi: 10.1586/14737140.6.7.1087 – volume: 281 start-page: 6020 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib41 article-title: Cathepsin S controls angiogenesis and tumour growth via matrix-derived angiogenic factors publication-title: J. Biol. Chem. doi: 10.1074/jbc.M509134200 – volume: 2 start-page: 737 year: 2000 ident: 10.1016/j.canlet.2009.07.014_bib52 article-title: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis publication-title: Nat. Cell Biol. doi: 10.1038/35036374 – volume: 23 start-page: 2224 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib39 article-title: Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1207338 – volume: 208 start-page: 108 year: 2006 ident: 10.1016/j.canlet.2009.07.014_bib53 article-title: Role of metaloproteinases MMP9 and MT1-MMP in CXCL2-promoted myleoma cell invasion across basement membranes publication-title: J. Pathol. doi: 10.1002/path.1876 – volume: 145 start-page: 825 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib11 article-title: Proteases in brain tumour progression publication-title: Acta Neurochir. (Wien.) doi: 10.1007/s00701-003-0097-z – volume: 385 start-page: 1017 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib29 article-title: Cysteine cathepsins in human cancer publication-title: Biol. Chem. doi: 10.1515/BC.2004.132 – volume: 11 start-page: 1835 year: 2005 ident: 10.1016/j.canlet.2009.07.014_bib40 article-title: Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma publication-title: Clin. Cancer Rest. doi: 10.1158/1078-0432.CCR-04-1887 – volume: 3/5 start-page: 362 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib8 article-title: Tumour-cell invasion and migration: diversity and escape mechanisms publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1075 – volume: 193 start-page: 367 year: 2001 ident: 10.1016/j.canlet.2009.07.014_bib6 article-title: Endothelial capillaries chemotactically attract tumour cells publication-title: J. Pathol. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1 – volume: 23 start-page: 4681 year: 2004 ident: 10.1016/j.canlet.2009.07.014_bib17 article-title: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumour cell invasion, tumour growth and angiogenesis publication-title: Oncogene doi: 10.1038/sj.onc.1207616 – volume: 145 start-page: 999 year: 2003 ident: 10.1016/j.canlet.2009.07.014_bib23 article-title: Soluble factors involved in glioma invasion publication-title: Acta Neurochir. (Wien.) doi: 10.1007/s00701-003-0132-0 |
SSID | ssj0005475 |
Score | 2.2466347 |
Snippet | Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study was to... Abstract Malignant glioma is characterized by rapid proliferation, high invasiveness into the surrounding brain and increased vascularity. The aim of the study... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 53 |
SubjectTerms | Angiogenesis Base Sequence Cancer Cathepsin B - metabolism Cathepsins - metabolism Cell adhesion & migration Cell culture Cell Line, Tumor Cell Proliferation - drug effects Cells, Cultured Chemokine CXCL12 - metabolism Chemokines (CXCL12/SDF-1) Cysteine cathepsins Endothelial Cells - cytology Endothelial Cells - drug effects Endothelial Cells - pathology Enzyme-Linked Immunosorbent Assay Enzymes Gene expression Gene Expression Regulation, Enzymologic Glioblastoma - physiopathology Glioblastoma invasion Hematology, Oncology and Palliative Medicine Humans Matrix metalloproteases Matrix Metalloproteinase 9 - metabolism Molecular Sequence Data Neoplasm Invasiveness Paracrine Communication Protease Inhibitors - pharmacology Studies Tumors Up-Regulation |
Title | Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9 |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0304383509005023 https://www.clinicalkey.es/playcontent/1-s2.0-S0304383509005023 https://dx.doi.org/10.1016/j.canlet.2009.07.014 https://www.ncbi.nlm.nih.gov/pubmed/19700239 https://www.proquest.com/docview/1506050676 https://www.proquest.com/docview/733811545 https://www.proquest.com/docview/745930856 |
Volume | 289 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqIiEuCMrXQql84LjuJrazXh9LYbuAtkJaKvVm2bEjFrbJimQRXPhL_EVmnKQtKqWIQy6JZ2zZLzMvzsyYkBdCCa8mLmHg6iyTeXzn8oKF4MAbKKGCwnzn-fF4diLfnmanW-Swz4XBsMrO9rc2PVrr7s6om83RerkcLfCnHnxfgcfDIiYcK35KqRDl-z8uhXnIWGwXGzNs3afPxRgvGD3MTle1Uu0nqbzOPV1HP6Mbmt4jdzv-SA_aId4nW6HcIbfn3R_yB-Tn0WpZOaDETXVmqS09DaXHLKsVAI3iNn1NY9cMWPfnIY2ZI8A6qftOF6-mLB2CwEeEQk2bzRl0R5flV4t7ale0rfHEnyK0GEIFyxI5KO4-0PCti7AtaVXQWBx2DQ9q-nJIF8Ooaj5_z_RDcjJ9_eFwxrpDGViecd0waYXTEyV0ruQ45y7lwSueFMIXQeTAXnKuZZHpsVYZT7h1qffOZ14ICwITLx6R7bIqwxNCrQjecu64slLyNIBax70ecxl8OvH5gIh-LUzeVSzHgzNWpg9N-2TaFcTDNLVJlIEVHBB2LrVuK3bc0D7rl9n02ahgPw24lBvk1J_kQt0ZgdqkpuYmMVeAelnyN6z_Q5-7PQ7NRTdYIxIuNR4Qev4YrARiypah2tRGCWBmyJb_0kRmWgABBy2PW4RfTJ9WMQn66X8P_Bm504ZdYPDeLtluvmzCc2BzjduLr-seuXXw5t3s-Bd_HEnn |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfGkGAXxPcKA3zgWK-J7dT1EQalwDohdZN2s-zYEYEurUiL4MK_xL_Ie06yDY0xxCGXxO_Zsp_f-8V-H4Q8F0p4NXIJA1NnmczjnssLFoIDa6CECgrjnacHw8mRfHecHW-QvS4WBt0qW93f6PSords3g3Y2B8uyHMzwUg_-r8DiYRITLq6R6xK2L5Yx2P1xzs9Dxmy72Jph8y5-Ljp5wfBhetq0lWo3SeVl9uky_Bnt0Pg2udUCSPqiGeMdshGqu-TGtL0iv0d-vpmXCweYeLU4sdRWnobKY5jVHCSN4jl9TWPXDGD35z6NoSMAO6n7TmevxiztA8FHlIWartYn0B0tq68WD9UucFtiyZ8iNEKEDMoKQSgeP9DwrXWxreiioDE77BI-1PRln876kdV0-oHp--Ro_Ppwb8Laqgwsz7heMWmF0yMldK7kMOcu5cErnhTCF0HkAF9yrmWR6aFWGU-4dan3zmdeCAsEIy8ekM1qUYVtQq0I3nLuuLJS8jQAW8e9HnIZfDryeY-Ibi1M3qYsx8oZc9P5pn0yzQpiNU1tEmVgBXuEnVItm5QdV7TPumU2XTgqKFADNuUKOvUnulC3WqA2qam5ScwFST1P-Zuw_0OfO50cmrNuMEkkPGrYI_T0M6gJlClbhcW6NkoANEO4_JcmMtMCEDhwedhI-Nn0aRWjoB_998CfkZuTw-m-2X978P4x2Wp8MNCTb4dsrr6swxOAdiv3NG7dX5xWS3U |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glioblastoma+and+endothelial+cells+cross-talk%2C+mediated+by+SDF-1%2C+enhances+tumour+invasion+and+endothelial+proliferation+by+increasing+expression+of+cathepsins+B%2C+S%2C+and+MMP-9&rft.jtitle=Cancer+letters&rft.au=Kenig%2C+Sasa&rft.au=Alonso%2C+Mar%C3%ADa+Beatriz+Dur%C3%A1n&rft.au=Mueller%2C+Margareta+M&rft.au=Lah%2C+Tamara+T&rft.date=2010-03-01&rft.eissn=1872-7980&rft.volume=289&rft.issue=1&rft.spage=53&rft_id=info:doi/10.1016%2Fj.canlet.2009.07.014&rft_id=info%3Apmid%2F19700239&rft.externalDocID=19700239 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03043835%2FS0304383510X00040%2Fcov150h.gif |